Cover Image
市場調查報告書

戒煙、尼古丁去癮產品的全球市場 2015-2023年 (尼古丁口香糖、貼片、錠劑劑、吸入藥、噴霧、舌下含片、其他) :產業分析、規模、佔有率、成長率、趨勢及預測

Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 298295
出版日期 內容資訊 英文 82 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
戒煙、尼古丁去癮產品的全球市場 2015-2023年 (尼古丁口香糖、貼片、錠劑劑、吸入藥、噴霧、舌下含片、其他) :產業分析、規模、佔有率、成長率、趨勢及預測 Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2016年01月12日 內容資訊: 英文 82 Pages
簡介

戒煙或尼古丁去癮,可透過尼古丁替代產品、電子香煙 (e香煙) 、Zyban (安非他酮) 和Chantix/Champix (Varenicline) 等抗憂鬱症藥和尼古丁受體激動劑等,多樣形態達成。還有戒煙即使不借助醫生的幫助也可能達成。

本報告提供全球戒煙、尼古丁去癮產品市場相關調查,市場概要,各類型、地區的市場分析與預測,競爭情形分析,及主要企業簡介等彙整。

第1章 序文

第2章 摘要整理

第3章 產業分析:戒煙、尼古丁去癮產品市場

  • 簡介、市場定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
  • 市場魅力分析:各地區
  • 競爭情形:熱圖分析

第4章 戒煙、尼古丁去癮產品市場區隔:各類型

  • 全球戒煙、尼古丁去癮產品市場收益:各類型
  • 全球戒煙、尼古丁去癮產品市場收益:各尼古丁替代療法
    • 尼古丁口香糖市場收益、分析
    • 尼古丁貼片市場收益、分析
    • 尼古丁噴霧市場收益、分析
    • 尼古丁吸入藥市場收益、分析
    • 尼古丁錠劑劑市場收益、分析
    • 尼古丁舌下含片市場收益、分析
  • 全球戒煙、尼古丁去癮產品市場收益:各藥物療法
    • 安非他酮 (Zyban) 市場收益、分析
    • Varenicline (Champix, Chantix) 市場收益、分析
  • 全球電子香煙 (e香煙) 市場收益

第5章 戒煙、尼古丁去癮產品市場區隔:各地區

  • 全球戒煙、尼古丁去癮產品市場收益:各地區
  • 北美
    • 各類型
    • 各國
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 企業簡介

  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Imperial Tobacco Company of India Limited.
  • McNeil AB
  • NJOY, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Revolymer PLC
  • 武田藥品工業

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

The global smoking cessation and nicotine de-addiction market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global smoking cessation and nicotine de-addiction market with respect to the segments based on the type of products, and their geographic analysis (by country). A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global smoking cessation and nicotine de-addiction market.

Based on type of products, the smoking cessation and nicotine de-addiction market includes nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW) The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

The global smoking cessation and nicotine de-addiction products market has been segmented as follows:

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Type

  • Nicotine Replacement Therapy Products
    • Nicotine Gums
    • Nicotine Transdermal Patches
    • Nicotine Lozenges
    • Nicotine Sprays
    • Nicotine Inhalers
    • Nicotine Subling ual Tablets
  • Drug Therapy
    • Zyban (bupropion)
    • Chantix/Champix (varenicline)
  • E-cigarettes

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America (LATAM)
    • Middle East and North Africa (MENA)

Table of Contents

1. Preface

2. Executive Summary

  • 2.1. Introduction
  • 2.2. Global Smoking Cessation and Nicotine De-addiction Products Market: Market Snapshot
  • 2.3. Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography and Analysis

3. Industry Analysis: Smoking Cessation and Nicotine De-addiction Products Market

  • 3.1. Introduction and Market Definition
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Rising awareness about smoking health hazards and smoking cessation therapy
      • 3.2.1.2. Introduction of new products
      • 3.2.1.3. Reimbursement for smoking cessation therapy
    • 3.2.2. Restraints
      • 3.2.2.1. Low awareness about smoking cessation products in developing economies
      • 3.2.2.2. Legal obligations dragging growth of several smoking cessation product segments
    • 3.2.3. Opportunity
      • 3.2.3.1. Research and development
      • 3.2.3.2. Market expansion in developing economies
  • 3.3. Market Attractiveness Analysis of Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
  • 3.4. Competitive Landscape: Heat Map Analysis

4. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Type

  • 4.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn)
  • 4.2. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Nicotine Replacement Therapies, 2013-2023 (US$ Mn)
    • 4.2.1. Global Nicotine Gums Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.2. Global Nicotine Patches Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.3. Global Nicotine Sprays Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.4. Global Nicotine Inhalers Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.5. Global Nicotine Lozenges Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.6. Global Nicotine Sub lingual Tablets Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.3. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Drug Therapy, 2013-2023 (US$ Mn)
    • 4.3.1. Global Bupropione (Zyban) Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.3.2. Global Varenicline (Champix, Chantix) Market Revenue, 2013-2023, (US$ Mn)
  • 4.4. Global E- Cigarettes Market Revenue, 2013-2023, (US$ Mn)

5. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Geography

  • 5.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Geography, 2013-2023 (US$ Mn)
  • 5.2. North America
    • 5.2.1. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.2.2. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.3. Europe
    • 5.3.1. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.3.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.4.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.5. Rest of the World
    • 5.5.1. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.5.2. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis

6. Company Profiles

  • 6.1. Cipla Ltd.
  • 6.2. GlaxoSmithKline plc
  • 6.3. Imperial Tobacco Company of India Limited.
  • 6.4. McNeil AB
  • 6.5. NJOY, Inc.
  • 6.6. Novartis International AG
  • 6.7. Pfizer, Inc.
  • 6.8. Revolymer PLC
  • 6.9. Takeda Pharmaceutical Co., Ltd.
Back to Top